- $1.16bn
- $1.44bn
- $568.09m
Bioventus Inc expected to post a loss of 15 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Allete, Gilead Sciences, Arcutis
U.S. STOCKS ON THE MOVE-FedEx, Liminal Biosciences, Kura Sushi
Bioventus up; co CEO steps down
Brief: Bioventus Announces CEO Leadership Change
Bioventus Inc reports results for the quarter ended in December - Earnings Summary
Brief: Bioventus reports Q4 sales USD 125.8 million
Brief: Bioventus Reports Q4 Adjusted Loss Per Share Of $0.06
Brief: Bioventus Enters Into An Amendment With Its Credit Agreement Lenders To Enhance Financial And Operational Flexibility
Bioventus Inc expected to post earnings of 5 cents a share - Earnings Preview
Bioventus Inc expected to post earnings of 5 cents a share - Earnings Preview
Bioventus Inc expected to post earnings of 5 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Rivian, Meta Platforms, Bioventus
Brief: Bioventus Enters Into Settlement Agreement To Preserve Maximum Optionality
Brief: Bioventus Inc Says, On December 6, 2022, Co Announced A Restructuring - Filing
Brief: Bioventus Files For Extension To File Form 10-Q For The Period Ended October 1, 2022
U.S. RESEARCH ROUNDUP-Beauty Health, Bioventus, Cabot
Bioventus hits lowest after 2022 sales forecast cut
Bioventus Inc reports results for the quarter ended in September - Earnings Summary